eBAG 3D STR for single use bioreactor solution

Dedicated to overcoming the limitations of single-use bag systems

Advanced eBAG 3D STR for dual-purpose single fermenter/bioreactors

In the ever-evolving landscape of Biotech, TECNIC's Single-Use eBAG 3D STR is ingeniously designed to seamlessly integrate with our dual-purpose Single-Use bioreactor. Devoted to overcoming the inherent limitations in single-use systems, the eBAG 3D STR stands as a purpose-built, cutting-edge solution tailored for mammalian culture. As well as, this innovative system is meticulously crafted to tackle specific challenges, offering a transformative leap in the capabilities of microbial bioprocessing.

Produced under stringent aseptic conditions and subjected to comprehensive sterilization, these bags ensure high sterility and minimal contamination risk. With customizable features catering to specific size configurations and fittings, they seamlessly integrate into manufacturing processes.

Developed and Manufactured in TECNIC ISO7 Clean Room, eBAG 3D STR is built tough with high-quality materials and undergo gamma irradiation. As a result, they are ready-to-use according to the strictest pharmaceutical industry standards and are available in various sizes (30L up to 1000L). They can withstand rigorous handling to ensure the safe containment of biopharmaceutical products. Perfectly designed to work with TECNIC ePILOT and ePROD Single Use Bioreactor ā‡€, manufactured to perfectly fit into the tank and fully adapt with the fully magnetic mixer to provide assurance in your process.

Guaranteed sterility for sensitive bioprocesses

Sterility assurance
Modular system
Cost-effectiveness
Various configuration options
Bag scalability
Quality assurance

Film technology for enhanced bioprocess

Our TECNIC Film Technology is specifically engineered for high-quality. Every one of our Single-Use products distinguishes itself by its unique five-layer structure, with each layer serving a specific function to optimize the integrity, durability, longevity and the sterility of the equipment.Ā 

Layer 1 - LPDE (50Ī¼m)
Layer 2 - TIE (10Ī¼m)
Layer 3 - EVOH (20Ī¼m)
Layer 4 - TIE (10Ī¼m)
Layer 5 - ULPDE (230Ī¼m)

In-house ISO 7 cleanroom for single-use standards

The manufacturing process for our single-use bioprocessing products, such as the eBAGĀ® 2D, 3D and SU vessel, strictly complies with the rigorous standards of an ISO 7 cleanroom This specific classification guarantees a highly controlled environment, characterized by a maximum particle count of 10,000 (ā‰„ 0.5 Ī¼m) per cubic meter of air.Ā 

This level of control is critical for ensuring the sterility and quality of our products, as it significantly reduces the risk of microbial and particulate contamination. By adhering to these standards, we ensure that each product meets the high expectations of purity and performance required in sensitive bioprocessing applications, providing our clients with reliable and consistent biotechnological solutions.

High standards in bioprocessing

The eBAG represents not just an innovation in cell culture film technology, but also sets new benchmarks in quality and regulatory compliance. Each eBAG is manufactured under stringent Good Manufacturing Practices (GMP), ensuring that every product meets the highest standards of quality and safety.

Sterilization is a critical aspect of production. We employ advanced radiation sterilization methods, effectively eliminating biological contaminants without compromising the product's integrity. This sterilization process is crucial for maintaining sterility and safety in sensitive applications.

Furthermore, the production of eBAG takes place in inhouse ISO 7 classified facilities. These cleanrooms are designed to control contamination and maintain an aseptic environment, essential for the manufacturing of biotechnological products. Adhering to ISO 7 standards ensures that each eBAG is produced in a controlled environment, minimizing the risk of cross-contamination and ensuring product consistency.

Together, these quality measures and regulatory compliance reflect our commitment to excellence in manufacturing eBAGĀ®, providing our clients with reliable and safe products for their critical bioprocessing applications.

Ā 

Test

Requirements

Results

USP <788> Particulate Matter in Injections

Pass

Pass

USP <88> Systemic Toxicity

Pass

Pass

USP <88> Intracutaneous

Pass

Pass

USP <88> Implantation

Pass

Pass

USP <87> Cytotoxicity, Agar Diffusion

Pass

Pass

USP <87> Cytotoxicity, Elution

Pass

Pass

USP <85> Kinetic-Chromogenic LAL

0,25 EU/ml

0,006 EU/ml

USP <661.1> Physicochemical-Non Volatile

15 mg

1 mg

USP <661.1> Physicochemical-Residue on Ignition

5 mg

1 mg

USP <661.1>Physicochemical-Heavy Metals

1 ppm

1 ppm

USP ā‰¤661.1>Physicochemical-Buffering Capacity

10 ml

1 ml

ISO 10993-4 In-Vitro Hemolysis Study

Non-haemolytic

Non-haemolytic

Irradiation Dosage

25-50 kGy

25-50 kGy

EP <3.2.2.1> Plastic Containers for Aqueous Solutions for Parenteral Infusion

Pass

Pass

Ā 

The eBAGĀ® represents not just an innovation in cell culture film technology, but also sets new benchmarks in quality and regulatory compliance. Each eBAGĀ®Ā  is manufactured under stringent Good Manufacturing Practices (GMP), ensuring that every product meets the highest standards of quality and safety.

Sterilization is a critical aspect of production. We employ advanced radiation sterilization methods, effectively eliminating biological contaminants without compromising the product's integrity. This sterilization process is crucial for maintaining sterility and safety in sensitive applications.

Furthermore, the production of eBAGĀ® takes place in inhouse ISO 7 classified facilities. These cleanrooms are designed to control contamination and maintain an aseptic environment, essential for the manufacturing of biotechnological products. Adhering to ISO 7 standards ensures that each eBAGĀ® is produced in a controlled environment, minimizing the risk of cross-contamination and ensuring product consistency.

Together, these quality measures and regulatory compliance reflect our commitment to excellence in manufacturing eBAGĀ®, providing our clients with reliable and safe products for their critical bioprocessing applications.

Ā 

Test

Requirements

Results

USP <788> Particulate Matter in Injections

Pass

Pass

USP <88> Systemic Toxicity

Pass

Pass

USP <88> Intracutaneous

Pass

Pass

USP <88> Implantation

Pass

Pass

USP <87> Cytotoxicity, Agar Diffusion

Pass

Pass

USP <87> Cytotoxicity, Elution

Pass

Pass

USP <85> Kinetic-Chromogenic LAL

0,25 EU/ml

0,006 EU/ml

USP <661.1> Physicochemical-Non Volatile

15 mg

1 mg

USP <661.1> Physicochemical-Residue on Ignition

5 mg

1 mg

USP <661.1>Physicochemical-Heavy Metals

1 ppm

1 ppm

USP ā‰¤661.1>Physicochemical-Buffering Capacity

10 ml

1 ml

ISO 10993-4 In-Vitro Hemolysis Study

Non-haemolytic

Non-haemolytic

Irradiation Dosage

25-50 kGy

25-50 kGy

EP <3.2.2.1> Plastic Containers for Aqueous Solutions for Parenteral Infusion

Pass

Pass

Ā 

The eBAGĀ® represents not just an innovation in cell culture film technology, but also sets new benchmarks in quality and regulatory compliance. Each eBAGĀ®Ā  is manufactured under stringent Good Manufacturing Practices (GMP), ensuring that every product meets the highest standards of quality and safety.

Sterilization is a critical aspect of production. We employ advanced radiation sterilization methods, effectively eliminating biological contaminants without compromising the product's integrity. This sterilization process is crucial for maintaining sterility and safety in sensitive applications.

Furthermore, the production of eBAGĀ® takes place in inhouse ISO 7 classified facilities. These cleanrooms are designed to control contamination and maintain an aseptic environment, essential for the manufacturing of biotechnological products. Adhering to ISO 7 standards ensures that each eBAGĀ® is produced in a controlled environment, minimizing the risk of cross-contamination and ensuring product consistency.

Together, these quality measures and regulatory compliance reflect our commitment to excellence in manufacturing eBAGĀ®, providing our clients with reliable and safe products for their critical bioprocessing applications.

 

Test

Need

Result

USP <788> Particulate Matter in Injections

Pass

Pass

USP <88> Systemic Toxicity

Pass

Pass

USP <88> Intracutaneous

Pass

Pass

USP <88> Implantation

Pass

Pass

USP <87> Cytotoxicity, Agar Diffusion

Pass

Pass

USP <87> Cytotoxicity, Elution

Pass

Pass

USP <85> Kinetic-Chromogenic LAL

0,25 EU/ml

0,006 EU/ml

USP <661.1> Physicochemical-Non Volatile

15 mg

1 mg

USP <661.1> Physicochemical-Residue on Ignition

5 mg

1 mg

USP <661.1>Physicochemical-Heavy Metals

1 ppm

1 ppm

USP ā‰¤661.1>Physicochemical-Buffering Capacity

10 ml

1 ml

ISO 10993-4 In-Vitro Hemolysis Study

Non-haemolytic

Non-haemolytic

Irradiation Dosage

25-50 kGy

25-50 kGy

EP <3.2.2.1> Plastic Containers for Aqueous Solutions for Parenteral Infusion

Pass

Pass

Ā 

Bag properties

Robust exterior layer
Sterile environment
Temperature resilience
GMP and ISO standards

Our sales team is ready to assist you with the most technical details.

Connect with our team today. Whether you have specific questions or are just beginning to explore, we're here to guide and assist. Reach out now and let's shape the future together.